An investigative expansion of a competing risk model for first failure site in locally advanced non-small cell lung cancer

References

• Bradley JD, Paulus R, Komaki R, et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial p. Lancet Oncol. 2015;16:187–199.
   PubMed Web of Science ®Google Scholar
• Cannon DM, Mehta MP, Adkison JB, et al. Dose-limiting toxicity after hypofractionated dose-escalated radiotherapy in non-small-cell lung cancer. J Clin Oncol. 2013;31:4343–4348.
   PubMed Web of Science ®Google Scholar
• Spratt DE, Diaz R, McElmurray J, et al. Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancer. Clin Nucl Med. 2010;35:237–243.
   PubMed Web of Science ®Google Scholar
• Konert T, Vogel W, MacManus MP, et al. PET/CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer: IAEA consensus report 2014. Radiother Oncol. 2015;116:27–34.
   PubMed Web of Science ®Google Scholar
• O'Connor JPB, Aboagye EO, Adams JE, et al. Imaging biomarker roadmap for cancer studies. Nat Rev Clin Oncol. 2017;14:169–186.
   PubMed Web of Science ®Google Scholar
• Lambin P, Leijenaar RTH, Deist TM, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14:749–762.
   PubMed Web of Science ®Google Scholar
• Nygård L, Vogelius IR, Fischer BM, et al. A competing risk model of first failure site after definitive chemoradiation therapy for locally advanced non-small cell lung cancer. J Thorac Oncol. 2018;13:559–567.
   PubMed Web of Science ®Google Scholar
• Ohri N, Duan F, Snyder BS, et al. Pretreatment 18F-FDG PET textural features in locally advanced non-small cell lung cancer: secondary analysis of ACRIN 6668/RTOG 0235. J Nucl Med. 2016;57:842–848.
   PubMed Web of Science ®Google Scholar
• Goldstraw P, Crowley J, Chansky K, et al. The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol. 2007;2:706–714.
   PubMed Web of Science ®Google Scholar
• Nygård L, Vogelius IR, Fischer BM, et al. Early lesion-specific (18)F-FDG PET response to chemotherapy predicts time to lesion progression in locally advanced non-small cell lung cancer. Radiother Oncol. 2016;118:460–464.
   PubMed Web of Science ®Google Scholar
• Wahl RL, Jacene H, Kasamon Y, et al. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50 Suppl 1:122S–150S.
   PubMed Web of Science ®Google Scholar
• Wolthaus JWH, Sonke J-J, van Herk M, et al. Comparison of different strategies to use four-dimensional computed tomography in treatment planning for lung cancer patients. Int J Radiat Oncol Biol Phys. 2008;70:1229–1238.
   PubMed Web of Science ®Google Scholar
• Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–481.
   Web of Science ®Google Scholar
• R: The R Project for Statistical Computing. 2008. [accessed 19/03/2019]. Available from: https://www.r-project.org/.
   Google Scholar
• Kim E, Wu H-G, Keam B, et al. Significance of 18 F-FDG PET parameters according to histologic subtype in the treatment outcome of stage III non small-cell lung cancer undergoing definitive concurrent chemoradiotherapy. Clin Lung Cancer. 2019;20:9–23.
   Web of Science ®Google Scholar
• Kandi M, Hoffmann L, Sloth Moeller D, et al. Local failure after radical radiotherapy of non-small cell lung cancer in relation to the planning FDG-PET/CT. Acta Oncol. 2018;57:813–819.
   PubMed Web of Science ®Google Scholar
• Ohri N, Bodner WR, Halmos B, et al. 18F-fluorodeoxyglucose/positron emission tomography predicts patterns of failure after definitive chemoradiation therapy for locally advanced non-small cell lung cancer. Int J Radiat Oncol. 2017;97:372–380.
   PubMed Web of Science ®Google Scholar
• Jochems A, El-Naqa I, Kessler M, et al. A prediction model for early death in non-small cell lung cancer patients following curative-intent chemoradiotherapy. Acta Oncol. 2018;57:226–230.
   PubMed Web of Science ®Google Scholar
• Walls GM, Hanna GG, Qi F, et al. Predicting outcomes from radical radiotherapy for non-small cell lung cancer: a systematic review of the existing literature. Front Oncol. 2018;8:433.
   PubMed Web of Science ®Google Scholar